Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Magnetic Resonance Imaging and Bioluminescence Imaging for Evaluating Tumor Burden in Orthotopic Colon Cancer.

Ravoori MK, Margalit O, Singh S, Kim SH, Wei W, Menter DG, DuBois RN, Kundra V.

Sci Rep. 2019 Apr 15;9(1):6100. doi: 10.1038/s41598-019-42230-w.

2.

Effects of excitation angle strategy on quantitative analysis of hyperpolarized pyruvate.

Walker CM, Fuentes D, Larson PEZ, Kundra V, Vigneron DB, Bankson JA.

Magn Reson Med. 2019 Jun;81(6):3754-3762. doi: 10.1002/mrm.27687. Epub 2019 Feb 22.

PMID:
30793791
3.

Metformin Reduces Renal Uptake of Radiotracers and Protects Kidneys from Radiation-Induced Damage.

Xiong C, Yin D, Li J, Huang Q, Ravoori MK, Kundra V, Zhu H, Yang Z, Lu Y, Li C.

Mol Pharm. 2019 Feb 4;16(2):808-815. doi: 10.1021/acs.molpharmaceut.8b01091. Epub 2019 Jan 16.

PMID:
30608713
4.

Routes to Potentially Safer T1 Magnetic Resonance Imaging Contrast in a Compact Plasmonic Nanoparticle with Enhanced Fluorescence.

Henderson L, Neumann O, Kaffes C, Zhang R, Marangoni V, Ravoori MK, Kundra V, Bankson J, Nordlander P, Halas NJ.

ACS Nano. 2018 Aug 28;12(8):8214-8223. doi: 10.1021/acsnano.8b03368. Epub 2018 Aug 16.

PMID:
30088917
5.

Polyethylenimine Modified Graphene-Oxide Electrochemical Immunosensor for the Detection of Glial Fibrillary Acidic Protein in Central Nervous System Injury.

Khetani S, Ozhukil Kollath V, Kundra V, Nguyen MD, Debert C, Sen A, Karan K, Sanati-Nezhad A.

ACS Sens. 2018 Apr 27;3(4):844-851. doi: 10.1021/acssensors.8b00076. Epub 2018 Mar 19.

PMID:
29516727
6.

The ABCs of BHD: An In-Depth Review of Birt-Hogg-Dubé Syndrome.

Gupta S, Kang HC, Ganeshan D, Morani A, Gautam R, Choyke PL, Kundra V.

AJR Am J Roentgenol. 2017 Dec;209(6):1291-1296. doi: 10.2214/AJR.17.18071. Epub 2017 Oct 5. Review.

PMID:
28981362
7.

In Vivo Assessment of Ovarian Tumor Response to Tyrosine Kinase Inhibitor Pazopanib by Using Hyperpolarized 13C-Pyruvate MR Spectroscopy and 18F-FDG PET/CT Imaging in a Mouse Model.

Ravoori MK, Singh SP, Lee J, Bankson JA, Kundra V.

Radiology. 2017 Dec;285(3):830-838. doi: 10.1148/radiol.2017161772. Epub 2017 Jul 13.

8.

Pattern and Distribution of Distant Metastases in Anaplastic Prostate Carcinoma: A Single-Institute Experience With 101 Patients.

Ganeshan D, Aparicio AM, Morani A, Kundra V.

AJR Am J Roentgenol. 2017 Aug;209(2):327-332. doi: 10.2214/AJR.16.17214. Epub 2017 Jun 7.

PMID:
28590819
9.

Optical Characteristics and Tumor Imaging Capabilities of Near Infrared Dyes in Free and Nano-Encapsulated Formulations Comprised of Viral Capsids.

Guerrero Y, Singh SP, Mai T, Murali RK, Tanikella L, Zahedi A, Kundra V, Anvari B.

ACS Appl Mater Interfaces. 2017 Jun 14;9(23):19601-19611. doi: 10.1021/acsami.7b03373. Epub 2017 May 31.

PMID:
28524652
10.

Role of Imaging in the Local Staging of Urothelial Carcinoma of the Bladder.

Lee CH, Tan CH, Faria SC, Kundra V.

AJR Am J Roentgenol. 2017 Jun;208(6):1193-1205. doi: 10.2214/AJR.16.17114. Epub 2017 Feb 22. Review.

PMID:
28225635
11.

Whole-body MRI in pediatric patients with cancer.

Guimarães MD, Noschang J, Teixeira SR, Santos MK, Lederman HM, Tostes V, Kundra V, Oliveira AD, Hochhegger B, Marchiori E.

Cancer Imaging. 2017 Feb 10;17(1):6. doi: 10.1186/s40644-017-0107-7. Review.

12.

Multimodal Magnetic Resonance and Near-Infrared-Fluorescent Imaging of Intraperitoneal Ovarian Cancer Using a Dual-Mode-Dual-Gadolinium Liposomal Contrast Agent.

Ravoori MK, Singh S, Bhavane R, Sood AK, Anvari B, Bankson J, Annapragada A, Kundra V.

Sci Rep. 2016 Dec 22;6:38991. doi: 10.1038/srep38991.

13.

Dose reduction in CT urography and vasculature phantom studies using model-based iterative reconstruction.

Page L, Wei W, Kundra V, Rong XJ.

J Appl Clin Med Phys. 2016 Nov 8;17(6):334-342. doi: 10.1120/jacmp.v17i6.6184.

14.

Ocular extramedullary myeloid leukaemia.

Ohanian M, Pemmaraju N, Rozovski U, Alattar ML, Estrov Z, Kundra V, Tung C, Ravandi F, Manning J, Abruzzo LV.

Br J Haematol. 2018 Mar;180(5):738-740. doi: 10.1111/bjh.14430. Epub 2016 Nov 23. No abstract available.

PMID:
27879987
15.

Can reduced field-of-view diffusion sequence help assess microsatellite instability in FIGO stage 1 endometrial cancer?

Bhosale P, Ramalingam P, Ma J, Iyer R, Soliman P, Frumovitz M, Kundra V.

J Magn Reson Imaging. 2017 Apr;45(4):1216-1224. doi: 10.1002/jmri.25427. Epub 2016 Aug 17.

PMID:
27532860
16.

Renal cell carcinoma associated with Xp11.2 translocation/TFE gene fusion: imaging findings in 21 patients.

Chen X, Zhu Q, Li B, Cui W, Zhou H, Duan N, Liu Y, Kundra V, Wang Z.

Eur Radiol. 2017 Feb;27(2):543-552. doi: 10.1007/s00330-016-4421-4. Epub 2016 Jun 2.

PMID:
27255396
17.

Performance evaluation of iterative reconstruction algorithms for achieving CT radiation dose reduction - a phantom study.

Dodge CT, Tamm EP, Cody DD, Liu X, Jensen CT, Wei W, Kundra V, Rong XJ.

J Appl Clin Med Phys. 2016 Mar 8;17(2):511-531. doi: 10.1120/jacmp.v17i2.5709.

18.

Angiotensin II increases gene expression after selective intra-arterial adenovirus delivery in a rabbit model assessed using in vivo SSTR2-based reporter imaging.

Singh SP, Ravoori MK, Dixon KA, Han L, Gupta S, Uthamanthil R, Wright KC, Kundra V.

EJNMMI Res. 2016 Dec;6(1):25. doi: 10.1186/s13550-016-0183-x. Epub 2016 Mar 17.

19.

Deletion of cyclooxygenase-2 inhibits K-ras-induced lung carcinogenesis.

Pan Y, Jiang Y, Tan L, Ravoori MK, Gagea M, Kundra V, Fischer SM, Yang P.

Oncotarget. 2015 Nov 17;6(36):38816-26. doi: 10.18632/oncotarget.5558.

20.

Virus-resembling nano-structures for near infrared fluorescence imaging of ovarian cancer HER2 receptors.

Guerrero YA, Bahmani B, Singh SP, Vullev VI, Kundra V, Anvari B.

Nanotechnology. 2015 Oct 30;26(43):435102. doi: 10.1088/0957-4484/26/43/435102. Epub 2015 Oct 7.

PMID:
26443474
21.

Feasibility of a reduced field-of-view diffusion-weighted (rFOV) sequence in assessment of myometrial invasion in patients with clinical FIGO stage I endometrial cancer.

Bhosale P, Ma J, Iyer R, Ramalingam P, Wei W, Soliman P, Frumovitz M, Kundra V.

J Magn Reson Imaging. 2016 Feb;43(2):316-24. doi: 10.1002/jmri.25001. Epub 2015 Jul 16.

22.

Tumor T1 Relaxation Time for Assessing Response to Bevacizumab Anti-Angiogenic Therapy in a Mouse Ovarian Cancer Model.

Ravoori MK, Nishimura M, Singh SP, Lu C, Han L, Hobbs BP, Pradeep S, Choi HJ, Bankson JA, Sood AK, Kundra V.

PLoS One. 2015 Jun 22;10(6):e0131095. doi: 10.1371/journal.pone.0131095. eCollection 2015.

23.

Diagnostic approach to hereditary renal cell carcinoma.

Gupta S, Kang HC, Ganeshan DM, Bathala TK, Kundra V.

AJR Am J Roentgenol. 2015 May;204(5):1031-41. doi: 10.2214/AJR.14.13514. Review.

PMID:
25905938
24.

Dynamic contrast-enhanced MRI for the detection of prostate cancer: meta-analysis.

Tan CH, Hobbs BP, Wei W, Kundra V.

AJR Am J Roentgenol. 2015 Apr;204(4):W439-48. doi: 10.2214/AJR.14.13373.

25.

Imaging acute complications in cancer patients: what should be evaluated in the emergency setting?

Guimaraes MD, Bitencourt AG, Marchiori E, Chojniak R, Gross JL, Kundra V.

Cancer Imaging. 2014 Apr 29;14:18. doi: 10.1186/1470-7330-14-18. Review.

26.

PBI-05204, a supercritical CO₂ extract of Nerium oleander, inhibits growth of human pancreatic cancer via targeting the PI3K/mTOR pathway.

Pan Y, Rhea P, Tan L, Cartwright C, Lee HJ, Ravoori MK, Addington C, Gagea M, Kundra V, Kim SJ, Newman RA, Yang P.

Invest New Drugs. 2015 Apr;33(2):271-9. doi: 10.1007/s10637-014-0190-6. Epub 2014 Dec 6.

27.

Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases.

Wan X, Corn PG, Yang J, Palanisamy N, Starbuck MW, Efstathiou E, Li Ning Tapia EM, Zurita AJ, Aparicio A, Ravoori MK, Vazquez ES, Robinson DR, Wu YM, Cao X, Iyer MK, McKeehan W, Kundra V, Wang F, Troncoso P, Chinnaiyan AM, Logothetis CJ, Navone NM.

Sci Transl Med. 2014 Sep 3;6(252):252ra122. doi: 10.1126/scitranslmed.3009332. Erratum in: Sci Transl Med. 2015 May 13;7(287):287er3. Tapia, Elsa M Li-Ning [corrected to Li Ning Tapia, Elsa M].

28.

Biomimetic and bioinspired materials for applications in biophotonics.

Anvari B, Del Pino P, Kundra V, Parak WJ.

J Biomed Opt. 2014;19(10):101501. doi: 10.1117/1.JBO.19.10.101501. No abstract available.

PMID:
25122592
29.

Functionalized polymeric nanoparticles loaded with indocyanine green as theranostic materials for targeted molecular near infrared fluorescence imaging and photothermal destruction of ovarian cancer cells.

Bahmani B, Guerrero Y, Bacon D, Kundra V, Vullev VI, Anvari B.

Lasers Surg Med. 2014 Sep;46(7):582-92. doi: 10.1002/lsm.22269. Epub 2014 Jun 24.

30.

Imaging features of fibrolamellar hepatocellular carcinoma.

Ganeshan D, Szklaruk J, Kundra V, Kaseb A, Rashid A, Elsayes KM.

AJR Am J Roentgenol. 2014 Mar;202(3):544-52. doi: 10.2214/AJR.13.11117. Review. Erratum in: AJR Am J Roentgenol. 2014 Apr;202(4):933. Elsayes, Khaled [corrected to Elsayes, Khaled M].

PMID:
24555590
31.

Staging, surveillance, and evaluation of response to therapy in renal cell carcinoma: role of MDCT.

Ganeshan D, Morani A, Ladha H, Bathala T, Kang H, Gupta S, Lalwani N, Kundra V.

Abdom Imaging. 2014 Feb;39(1):66-85.

PMID:
24077815
32.

Imaging features of carcinoid tumors of the gastrointestinal tract.

Ganeshan D, Bhosale P, Yang T, Kundra V.

AJR Am J Roentgenol. 2013 Oct;201(4):773-86. doi: 10.2214/AJR.12.9758. Review.

PMID:
24059366
33.

Tumour angiogenesis regulation by the miR-200 family.

Pecot CV, Rupaimoole R, Yang D, Akbani R, Ivan C, Lu C, Wu S, Han HD, Shah MY, Rodriguez-Aguayo C, Bottsford-Miller J, Liu Y, Kim SB, Unruh A, Gonzalez-Villasana V, Huang L, Zand B, Moreno-Smith M, Mangala LS, Taylor M, Dalton HJ, Sehgal V, Wen Y, Kang Y, Baggerly KA, Lee JS, Ram PT, Ravoori MK, Kundra V, Zhang X, Ali-Fehmi R, Gonzalez-Angulo AM, Massion PP, Calin GA, Lopez-Berestein G, Zhang W, Sood AK.

Nat Commun. 2013;4:2427. doi: 10.1038/ncomms3427.

34.

Somatostatin receptor type 2-based reporter expression after plasmid-based in vivo gene delivery to non-small cell lung cancer.

Han L, Ravoori M, Wu G, Sakai R, Yan S, Singh S, Xu K, Roth JA, Ji L, Kundra V.

Mol Imaging. 2013 Oct;12(7):1-10.

35.

Noninvasive assessment of gene transfer and expression by in vivo functional and morphologic imaging in a rabbit tumor model.

Ravoori MK, Han L, Singh SP, Dixon K, Duggal J, Liu P, Uthamanthil R, Gupta S, Wright KC, Kundra V.

PLoS One. 2013 Jun 10;8(6):e62371. doi: 10.1371/journal.pone.0062371. Print 2013. Erratum in: PLoS One. 2013;8(10). doi: 10.1371/annotation/d6e7cf90-9e67-4d3b-8a2a-40d57be92bce.

36.

Visualizing the prostate gland by MR imaging in young and old mice.

Ravoori M, Duggal J, Gagea M, Han L, Singh S, Liu P, Wei W, Ragan DK, Bankson JA, Ma J, Kundra V.

PLoS One. 2013;8(3):e55746. doi: 10.1371/journal.pone.0055746. Epub 2013 Mar 1.

37.

Conspicuity of bone metastases on fast Dixon-based multisequence whole-body MRI: clinical utility per sequence.

Costelloe CM, Madewell JE, Kundra V, Harrell RK, Bassett RL Jr, Ma J.

Magn Reson Imaging. 2013 Jun;31(5):669-75. doi: 10.1016/j.mri.2012.10.017. Epub 2013 Jan 3.

38.

Current update on cytogenetics, taxonomy, diagnosis, and management of adrenocortical carcinoma: what radiologists should know.

Ganeshan D, Bhosale P, Kundra V.

AJR Am J Roentgenol. 2012 Dec;199(6):1283-93. doi: 10.2214/AJR.11.8282. Review.

PMID:
23169720
39.

Diffusion-weighted MRI in the detection of prostate cancer: meta-analysis.

Tan CH, Wei W, Johnson V, Kundra V.

AJR Am J Roentgenol. 2012 Oct;199(4):822-9.

40.

Carcinoid tumours: predicting the location of the primary neoplasm based on the sites of metastases.

Bhosale P, Shah A, Wei W, Varadhachary G, Johnson V, Shah V, Kundra V.

Eur Radiol. 2013 Feb;23(2):400-7. doi: 10.1007/s00330-012-2615-y. Epub 2012 Aug 30.

PMID:
22932740
41.

Common and uncommon adult unilateral renal masses other than renal cell carcinoma.

Le O, Roy A, Silverman PM, Kundra V.

Cancer Imaging. 2012 May 21;12:194-204. doi: 10.1102/1470-7330.2012.0019. Review.

42.

Common and uncommon bilateral adult renal masses.

Roy A, Le O, Silverman PM, Kundra V.

Cancer Imaging. 2012 May 21;12:205-11. doi: 10.1102/1470-7330.2012.0022. Review.

43.

Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer.

Fu S, Hennessy BT, Ng CS, Ju Z, Coombes KR, Wolf JK, Sood AK, Levenback CF, Coleman RL, Kavanagh JJ, Gershenson DM, Markman M, Dice K, Howard A, Li J, Li Y, Stemke-Hale K, Dyer M, Atkinson E, Jackson E, Kundra V, Kurzrock R, Bast RC Jr, Mills GB.

Gynecol Oncol. 2012 Jul;126(1):47-53. doi: 10.1016/j.ygyno.2012.04.006. Epub 2012 Apr 6.

44.

Reproducibility and comparison of DCE-MRI and DCE-CT perfusion parameters in a rat tumor model.

Ng CS, Waterton JC, Kundra V, Brammer D, Ravoori M, Han L, Wei W, Klumpp S, Johnson VE, Jackson EF.

Technol Cancer Res Treat. 2012 Jun;11(3):279-88. Epub 2012 Mar 15.

PMID:
22417064
45.

Effect of transforming growth factor beta (TGF-β) receptor I kinase inhibitor on prostate cancer bone growth.

Wan X, Li ZG, Yingling JM, Yang J, Starbuck MW, Ravoori MK, Kundra V, Vazquez E, Navone NM.

Bone. 2012 Mar;50(3):695-703. doi: 10.1016/j.bone.2011.11.022. Epub 2011 Dec 7.

46.

Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer.

Coleman RL, Duska LR, Ramirez PT, Heymach JV, Kamat AA, Modesitt SC, Schmeler KM, Iyer RB, Garcia ME, Miller DL, Jackson EF, Ng CS, Kundra V, Jaffe R, Sood AK.

Lancet Oncol. 2011 Nov;12(12):1109-17. doi: 10.1016/S1470-2045(11)70244-3. Epub 2011 Oct 10.

47.

Dual inhibition of tumor energy pathway by 2-deoxyglucose and metformin is effective against a broad spectrum of preclinical cancer models.

Cheong JH, Park ES, Liang J, Dennison JB, Tsavachidou D, Nguyen-Charles C, Wa Cheng K, Hall H, Zhang D, Lu Y, Ravoori M, Kundra V, Ajani J, Lee JS, Ki Hong W, Mills GB.

Mol Cancer Ther. 2011 Dec;10(12):2350-62. doi: 10.1158/1535-7163.MCT-11-0497. Epub 2011 Oct 12.

48.

Fast Dixon whole-body MRI for detecting distant cancer metastasis: a preliminary clinical study.

Costelloe CM, Kundra V, Ma J, Chasen BA, Rohren EM, Bassett RL Jr, Madewell JE.

J Magn Reson Imaging. 2012 Feb;35(2):399-408. doi: 10.1002/jmri.22815. Epub 2011 Oct 11.

49.

Quality initiatives: CT radiation dose reduction: how to implement change without sacrificing diagnostic quality.

Tamm EP, Rong XJ, Cody DD, Ernst RD, Fitzgerald NE, Kundra V.

Radiographics. 2011 Nov-Dec;31(7):1823-32. doi: 10.1148/rg.317115027. Epub 2011 Oct 3.

PMID:
21969662
50.

Imaging long-term fate of intramyocardially implanted mesenchymal stem cells in a porcine myocardial infarction model.

Perin EC, Tian M, Marini FC 3rd, Silva GV, Zheng Y, Baimbridge F, Quan X, Fernandes MR, Gahremanpour A, Young D, Paolillo V, Mukhopadhyay U, Borne AT, Uthamanthil R, Brammer D, Jackson J, Decker WK, Najjar AM, Thomas MW, Volgin A, Rabinovich B, Soghomonyan S, Jeong HJ, Rios JM, Steiner D, Robinson S, Mawlawi O, Pan T, Stafford J, Kundra V, Li C, Alauddin MM, Willerson JT, Shpall E, Gelovani JG.

PLoS One. 2011;6(9):e22949. doi: 10.1371/journal.pone.0022949. Epub 2011 Sep 1.

Supplemental Content

Loading ...
Support Center